GJD4
geneOn this page
Also known as CX40.1FLJ90023
Summary
GJD4 (gap junction protein delta 4, HGNC:23296) is a protein-coding gene on chromosome 10p11.21, encoding Gap junction delta-4 protein (Q96KN9). One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.
Connexins, such as GJD4, are involved in the formation of gap junctions, intercellular conduits that directly connect the cytoplasms of contacting cells. Each gap junction channel is formed by docking of 2 hemichannels, each of which contains 6 connexin subunits (Sohl et al., 2003 [PubMed 12881038]).
Source: NCBI Gene 219770 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 83 total
- MANE Select transcript:
NM_153368
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23296 |
| Approved symbol | GJD4 |
| Name | gap junction protein delta 4 |
| Location | 10p11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CX40.1, FLJ90023 |
| Ensembl gene | ENSG00000177291 |
| Ensembl biotype | protein_coding |
| OMIM | 611922 |
| Entrez | 219770 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000321660
RefSeq mRNA: 1 — MANE Select: NM_153368
NM_153368
CCDS: CCDS7191
Canonical transcript exons
ENST00000321660 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001242724 | 35607578 | 35608935 |
| ENSE00001242732 | 35605341 | 35605631 |
Expression profiles
Bgee: expression breadth broad, 31 present calls, max score 84.65.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0208 / max 14.7441, expressed in 8 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 104696 | 0.0109 | 3 |
| 104695 | 0.0099 | 3 |
Top tissues by expression
198 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.65 | gold quality |
| kidney epithelium | UBERON:0004819 | 82.27 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 79.02 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 78.80 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 78.63 | gold quality |
| upper arm skin | UBERON:0004263 | 78.47 | gold quality |
| myocardium | UBERON:0002349 | 73.62 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 72.65 | gold quality |
| heart right ventricle | UBERON:0002080 | 70.08 | gold quality |
| vastus lateralis | UBERON:0001379 | 70.02 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 69.52 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 69.33 | gold quality |
| quadriceps femoris | UBERON:0001377 | 68.87 | gold quality |
| vena cava | UBERON:0004087 | 67.32 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 66.76 | gold quality |
| biceps brachii | UBERON:0001507 | 64.66 | gold quality |
| parotid gland | UBERON:0001831 | 64.62 | gold quality |
| gingival epithelium | UBERON:0001949 | 64.58 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 64.30 | gold quality |
| superficial temporal artery | UBERON:0001614 | 63.98 | gold quality |
| gingiva | UBERON:0001828 | 63.87 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 63.68 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 63.19 | gold quality |
| cartilage tissue | UBERON:0002418 | 62.82 | gold quality |
| epithelium of mammary gland | UBERON:0003244 | 62.01 | gold quality |
| secondary oocyte | CL:0000655 | 61.97 | gold quality |
| mammary duct | UBERON:0001765 | 61.88 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 61.81 | gold quality |
| postcentral gyrus | UBERON:0002581 | 61.72 | gold quality |
| body of tongue | UBERON:0011876 | 61.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting GJD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-4735-5P | 99.43 | 68.49 | 1780 |
| HSA-MIR-6809-5P | 99.13 | 68.45 | 1223 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
| HSA-MIR-1304-3P | 98.29 | 66.44 | 1207 |
| HSA-MIR-660-3P | 98.14 | 66.04 | 1434 |
| HSA-MIR-1182 | 96.41 | 64.89 | 336 |
| HSA-MIR-635 | 96.00 | 65.54 | 687 |
| HSA-MIR-6774-5P | 95.94 | 65.18 | 722 |
Literature-anchored findings (GeneRIF, showing 4)
- expression patterns differ from mouse orthologs [Cx30.2; Cx40.1] (PMID:12881038)
- The data show that induced expression of either Cx37 or Cx40 in Cx43-expressing cells can selectively alter the intercellular exchange of some molecules without affecting the transfer of others. (PMID:22729648)
- Connexin40 regulates platelet function. (PMID:24096827)
- Human deltoid muscle biopsies of 5 Chilean dysferlinopathy patients exhibited the presence of muscular connexins (Cx40.1, Cx43 and Cx45). (PMID:27229680)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ENSDARG00000116895 | |
| mus_musculus | Gjd4 | ENSMUSG00000036855 |
| rattus_norvegicus | Gjd4 | ENSRNOG00000018407 |
Paralogs (20): GJA8 (ENSG00000121634), GJB6 (ENSG00000121742), GJA3 (ENSG00000121743), GJA9 (ENSG00000131233), GJA10 (ENSG00000135355), GJA1 (ENSG00000152661), GJD2 (ENSG00000159248), GJB7 (ENSG00000164411), GJB2 (ENSG00000165474), GJB1 (ENSG00000169562), GJC3 (ENSG00000176402), GJC1 (ENSG00000182963), GJD3 (ENSG00000183153), GJA4 (ENSG00000187513), GJB3 (ENSG00000188910), GJB5 (ENSG00000189280), GJB4 (ENSG00000189433), GJC2 (ENSG00000198835), GJE1 (ENSG00000203733), GJA5 (ENSG00000265107)
Protein
Protein identifiers
Gap junction delta-4 protein — Q96KN9 (reviewed: Q96KN9)
Alternative names: Connexin-40.1
All UniProt accessions (1): Q96KN9
UniProt curated annotations — full annotation on UniProt →
Function. One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell.
Subunit / interactions. A connexon is composed of a hexamer of connexins.
Subcellular location. Cell membrane. Cell junction. Gap junction.
Tissue specificity. Expressed in pancreas, kidney, skeletal muscle, liver, placenta, and heart.
Similarity. Belongs to the connexin family. Delta-type subfamily.
RefSeq proteins (1): NP_699199* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000500 | Connexin | Family |
| IPR013092 | Connexin_N | Domain |
| IPR017990 | Connexin_CS | Conserved_site |
| IPR019570 | Connexin_CCC | Domain |
| IPR038359 | Connexin_N_sf | Homologous_superfamily |
Pfam: PF00029
UniProt features (33 total): helix 10, topological domain 5, transmembrane region 4, strand 4, sequence variant 3, compositionally biased region 2, turn 2, chain 1, region of interest 1, sequence conflict 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8GN7 | ELECTRON MICROSCOPY | 3 |
| 8GN8 | ELECTRON MICROSCOPY | 3.5 |
| 8GNB | ELECTRON MICROSCOPY | 3.9 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96KN9-F1 | 68.92 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-190861 | Gap junction assembly |
MSigDB gene sets: 49 (showing top):
GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_SKELETAL_MUSCLE_TISSUE_REGENERATION, MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER, GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH, GOBP_GROWTH, GOBP_REGENERATION, REACTOME_MEMBRANE_TRAFFICKING, GOBP_CELL_CELL_SIGNALING, GOBP_TISSUE_REGENERATION, GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, REACTOME_GAP_JUNCTION_ASSEMBLY, GOCC_CELL_CELL_JUNCTION, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_REGULATION_OF_GROWTH, GOCC_MEMBRANE_PROTEIN_COMPLEX
GO Biological Process (4): cell-cell signaling (GO:0007267), regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717), cell communication (GO:0007154), transmembrane transport (GO:0055085)
GO Molecular Function (1): gap junction channel activity (GO:0005243)
GO Cellular Component (5): connexin complex (GO:0005922), plasma membrane (GO:0005886), gap junction (GO:0005921), membrane (GO:0016020), anchoring junction (GO:0070161)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Gap junction trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular process | 2 |
| cell communication | 1 |
| signaling | 1 |
| satellite cell activation involved in skeletal muscle regeneration | 1 |
| regulation of skeletal muscle tissue regeneration | 1 |
| regulation of cell activation | 1 |
| transport | 1 |
| wide pore channel activity | 1 |
| gap junction | 1 |
| plasma membrane protein complex | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell-cell junction | 1 |
| cellular anatomical structure | 1 |
| cell junction | 1 |
Protein interactions and networks
STRING
446 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GJD4 | FXYD4 | P59646 | 961 |
| GJD4 | ZBBX | A8MT70 | 524 |
| GJD4 | TBC1D22B | Q9NU19 | 512 |
| GJD4 | NRSN2 | Q9GZP1 | 480 |
| GJD4 | PLCD4 | Q9BRC7 | 462 |
| GJD4 | CALHM1 | Q8IU99 | 450 |
| GJD4 | FSTL5 | Q8N475 | 449 |
| GJD4 | CHRNA2 | Q15822 | 433 |
| GJD4 | SYCP2 | Q9BX26 | 429 |
| GJD4 | WDR49 | Q8IV35 | 395 |
| GJD4 | GJE1 | A6NN92 | 375 |
| GJD4 | RASL11A | Q6T310 | 365 |
| GJD4 | SLC38A11 | Q08AI6 | 364 |
| GJD4 | FAM78A | Q5JUQ0 | 359 |
| GJD4 | PHYHIP | Q92561 | 358 |
IntAct
126 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GJD4 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| GJD4 | TJP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | PDZD2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | HTRA3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | GORASP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | PATJ | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | LNX2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | GORASP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | TJP1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | NOS1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | RADIL | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | APBA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | TJP3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | HTRA4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SNX27 | GJD4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | HTRA1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | DLG3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | FRMPD2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | SYNJ2BP | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | DLG1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | DLG2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | ERBIN | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| DLG4 | GJD4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| TIAM2 | GJD4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | PDZK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | NHERF4 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | MPDZ | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | GRIP2 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| GJD4 | MAGI3 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
BioGRID (13): TMEM31 (Two-hybrid), GJD4 (Affinity Capture-MS), GJD4 (Affinity Capture-MS), PTER (Affinity Capture-MS), GJD4 (Affinity Capture-MS), STXBP3 (Affinity Capture-MS), STXBP1 (Affinity Capture-MS), MBLAC2 (Affinity Capture-MS), FOXK2 (Affinity Capture-MS), DPP9 (Affinity Capture-MS), STXBP2 (Affinity Capture-MS), GJD4 (Affinity Capture-MS), GJD4 (Two-hybrid)
ESM2 similar proteins: A0A0U1RQ45, A0A0U1RQS6, A0A2R8YCJ5, A2A699, A2AEV7, A6NGB7, A6NJG2, A6NKF7, A6NKL6, A6NL88, A8MVW0, A9JSM3, B2RU40, B8ZZ34, C9JH25, D4A9R4, J3QNX5, P0CG09, P98077, Q0VD38, Q14761, Q17QH7, Q29RK8, Q2KJ18, Q2M3V2, Q3SX20, Q5BJT1, Q5HZJ5, Q5RKR3, Q5T442, Q64697, Q69YZ2, Q6PB97, Q6PCT2, Q6UXK2, Q6ZMQ8, Q6ZVH7, Q6ZW31, Q80XF7, Q8BLS7
Diamond homologs: A2VE67, A3KN25, A4GG66, A4GVD1, A4IFL1, A6XKM2, O18968, O57474, O93533, O95377, O95452, P08033, P08034, P08050, P08983, P14154, P16863, P16864, P17302, P18246, P18860, P18861, P21994, P23242, P25305, P28228, P28229, P28230, P28231, P28232, P28233, P28234, P28235, P28236, P29033, P29414, P29415, P33725, P35212, P36381
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 81 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Assembly and cell surface presentation of NMDA receptors | 8 | 38.3× | 2e-09 |
| Neurexins and neuroligins | 10 | 37.1× | 2e-11 |
| Protein-protein interactions at synapses | 6 | 30.1× | 3e-06 |
| RHOA GTPase cycle | 5 | 7.0× | 7e-03 |
| Neuronal System | 6 | 5.0× | 9e-03 |
| Signaling by Rho GTPases | 7 | 4.5× | 8e-03 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 7 | 4.4× | 8e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| establishment or maintenance of epithelial cell apical/basal polarity | 10 | 75.5× | 2e-14 |
| protein localization to synapse | 6 | 59.7× | 9e-08 |
| receptor clustering | 6 | 48.6× | 2e-07 |
| regulation of postsynaptic membrane neurotransmitter receptor levels | 7 | 45.1× | 4e-08 |
| protein-containing complex assembly | 9 | 13.3× | 2e-06 |
| cell-cell adhesion | 9 | 11.9× | 4e-06 |
| chemical synaptic transmission | 7 | 7.0× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
83 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 75 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
192 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:35605628:GTGG:G | donor_gain | 1.0000 |
| 10:35605632:G:GG | donor_gain | 1.0000 |
| 10:35605630:GG:G | donor_gain | 0.9900 |
| 10:35605631:GG:G | donor_gain | 0.9900 |
| 10:35605632:GTGA:G | donor_loss | 0.9900 |
| 10:35605633:T:TG | donor_loss | 0.9900 |
| 10:35605634:GAG:G | donor_loss | 0.9900 |
| 10:35605629:TGG:T | donor_gain | 0.9800 |
| 10:35605630:GGG:G | donor_gain | 0.9800 |
| 10:35605636:G:C | donor_loss | 0.9800 |
| 10:35607572:TTCCA:T | acceptor_loss | 0.9800 |
| 10:35607573:TCCA:T | acceptor_loss | 0.9800 |
| 10:35607574:CCAG:C | acceptor_loss | 0.9800 |
| 10:35607575:CA:C | acceptor_loss | 0.9800 |
| 10:35607576:A:AG | acceptor_gain | 0.9800 |
| 10:35607576:A:AT | acceptor_loss | 0.9800 |
| 10:35607577:G:A | acceptor_loss | 0.9800 |
| 10:35607577:G:GG | acceptor_gain | 0.9800 |
| 10:35607577:GGAAA:G | acceptor_gain | 0.9800 |
| 10:35607576:AG:A | acceptor_gain | 0.9700 |
| 10:35607577:GG:G | acceptor_gain | 0.9700 |
| 10:35607577:GGA:G | acceptor_gain | 0.9700 |
| 10:35607577:GGAA:G | acceptor_gain | 0.9700 |
| 10:35605563:G:GT | donor_gain | 0.8800 |
| 10:35605979:A:T | donor_gain | 0.8300 |
| 10:35605934:T:TA | donor_gain | 0.8100 |
| 10:35605984:G:GT | donor_gain | 0.8100 |
| 10:35605571:G:GT | donor_gain | 0.7600 |
| 10:35605854:G:GT | donor_gain | 0.7600 |
| 10:35605978:G:GT | donor_gain | 0.7400 |
AlphaMissense
2343 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:35607668:T:G | F52C | 0.998 |
| 10:35607667:T:C | F52L | 0.994 |
| 10:35607669:T:A | F52L | 0.994 |
| 10:35607669:T:G | F52L | 0.994 |
| 10:35607668:T:C | F52S | 0.992 |
| 10:35607673:T:A | C54S | 0.989 |
| 10:35607674:G:C | C54S | 0.989 |
| 10:35607708:C:G | C65W | 0.989 |
| 10:35607674:G:A | C54Y | 0.988 |
| 10:35607707:G:A | C65Y | 0.987 |
| 10:35607718:T:C | F69L | 0.987 |
| 10:35607720:C:A | F69L | 0.987 |
| 10:35607720:C:G | F69L | 0.987 |
| 10:35608071:C:G | C186W | 0.986 |
| 10:35607706:T:A | C65S | 0.985 |
| 10:35607707:G:C | C65S | 0.985 |
| 10:35607776:C:G | P88R | 0.985 |
| 10:35607790:A:C | S93R | 0.985 |
| 10:35607792:C:A | S93R | 0.985 |
| 10:35607792:C:G | S93R | 0.985 |
| 10:35607677:A:T | N55I | 0.984 |
| 10:35607694:T:A | C61S | 0.984 |
| 10:35607695:G:C | C61S | 0.984 |
| 10:35608095:G:C | K194N | 0.984 |
| 10:35608095:G:T | K194N | 0.984 |
| 10:35607787:T:C | F92L | 0.983 |
| 10:35607789:C:A | F92L | 0.983 |
| 10:35607789:C:G | F92L | 0.983 |
| 10:35607678:C:A | N55K | 0.982 |
| 10:35607678:C:G | N55K | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1001272049 (10:35605280 G>A), RS1001723246 (10:35605014 A>C), RS1002046905 (10:35608801 A>C,G), RS1002329257 (10:35603604 G>A,C), RS1002682144 (10:35603829 T>C), RS1003355656 (10:35606468 T>C), RS1003443232 (10:35607248 A>C,G), RS1003754276 (10:35606918 A>G), RS1004018827 (10:35603880 T>C), RS1004069618 (10:35606604 G>A), RS1004578246 (10:35609171 A>G), RS1006575891 (10:35605179 G>C), RS1007180092 (10:35605877 C>G), RS1007416087 (10:35608853 A>C,G), RS1007468516 (10:35609129 C>A,T)
Disease associations
OMIM: gene MIM:611922 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: other ic — Connexins and Pannexins
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| incobotulinumtoxinA | decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases expression, affects cotreatment | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Calcium, Carbenoxolone